Treatment of the elderly patient with haematological cancer.
Ugeskr Laeger
; 186(4)2024 01 22.
Article
en Da
| MEDLINE
| ID: mdl-38305321
ABSTRACT
During the last two decades, novel targeted therapies, in particular, ¼small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Hematológicas
/
Antineoplásicos
Límite:
Aged
/
Humans
Idioma:
Da
Revista:
Ugeskr Laeger
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Dinamarca